180 related articles for article (PubMed ID: 15274301)
1. Selenium compounds regulate p53 by common and distinctive mechanisms.
Smith ML; Lancia JK; Mercer TI; Ip C
Anticancer Res; 2004; 24(3a):1401-8. PubMed ID: 15274301
[TBL] [Abstract][Full Text] [Related]
2. Differential apoptotic response of human cancer cells to organoselenium compounds.
Suzuki M; Endo M; Shinohara F; Echigo S; Rikiishi H
Cancer Chemother Pharmacol; 2010 Aug; 66(3):475-84. PubMed ID: 19940991
[TBL] [Abstract][Full Text] [Related]
3. Selenium protection from DNA damage involves a Ref1/p53/Brca1 protein complex.
Fischer JL; Lancia JK; Mathur A; Smith ML
Anticancer Res; 2006; 26(2A):899-904. PubMed ID: 16619485
[TBL] [Abstract][Full Text] [Related]
4. New careers for antioxidants.
Brash DE; Havre PA
Proc Natl Acad Sci U S A; 2002 Oct; 99(22):13969-71. PubMed ID: 12391310
[No Abstract] [Full Text] [Related]
5. Selenium and anticarcinogenesis: underlying mechanisms.
Jackson MI; Combs GF
Curr Opin Clin Nutr Metab Care; 2008 Nov; 11(6):718-26. PubMed ID: 18827575
[TBL] [Abstract][Full Text] [Related]
6. Differential involvement of reactive oxygen species in apoptosis induced by two classes of selenium compounds in human prostate cancer cells.
Li GX; Hu H; Jiang C; Schuster T; Lü J
Int J Cancer; 2007 May; 120(9):2034-43. PubMed ID: 17230520
[TBL] [Abstract][Full Text] [Related]
7. Selenomethionine regulation of p53 by a ref1-dependent redox mechanism.
Seo YR; Kelley MR; Smith ML
Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14548-53. PubMed ID: 12357032
[TBL] [Abstract][Full Text] [Related]
8. Selenocystine induces caspase-independent apoptosis in MCF-7 human breast carcinoma cells with involvement of p53 phosphorylation and reactive oxygen species generation.
Chen T; Wong YS
Int J Biochem Cell Biol; 2009 Mar; 41(3):666-76. PubMed ID: 18718551
[TBL] [Abstract][Full Text] [Related]
9. p53-Dependent growth arrest and altered p53-immunoreactivity following metabolic labelling with 32P ortho-phosphate in human fibroblasts.
Bond JA; Webley K; Wyllie FS; Jones CJ; Craig A; Hupp T; Wynford-Thomas D
Oncogene; 1999 Jun; 18(25):3788-92. PubMed ID: 10391688
[TBL] [Abstract][Full Text] [Related]
10. Mutations in serines 15 and 20 of human p53 impair its apoptotic activity.
Unger T; Sionov RV; Moallem E; Yee CL; Howley PM; Oren M; Haupt Y
Oncogene; 1999 May; 18(21):3205-12. PubMed ID: 10359526
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of 76Se-methylselenocysteine compared with that of 77Se-selenomethionine and 82Se-selenite.
Suzuki KT; Doi C; Suzuki N
Toxicol Appl Pharmacol; 2006 Dec; 217(2):185-95. PubMed ID: 17056079
[TBL] [Abstract][Full Text] [Related]
12. Benzo(a)pyrene increases phosphorylation of p53 at serine 392 in relation to p53 induction and cell death in MCF-7 cells.
Tampio M; Loikkanen J; Myllynen P; Mertanen A; Vähäkangas KH
Toxicol Lett; 2008 May; 178(3):152-9. PubMed ID: 18440733
[TBL] [Abstract][Full Text] [Related]
13. Selenomethionine inhibits ultraviolet radiation-induced p53 transactivation.
Traynor NJ; McKenzie RC; Beckett GJ; Gibbs NK
Photodermatol Photoimmunol Photomed; 2006 Dec; 22(6):297-303. PubMed ID: 17100737
[TBL] [Abstract][Full Text] [Related]
14. Redox factor 1 (Ref-1) enhances specific DNA binding of p53 by promoting p53 tetramerization.
Hanson S; Kim E; Deppert W
Oncogene; 2005 Feb; 24(9):1641-7. PubMed ID: 15674341
[TBL] [Abstract][Full Text] [Related]
15. Selenium activates p53 and p38 pathways and induces caspase-independent cell death in cervical cancer cells.
Rudolf E; Rudolf K; Cervinka M
Cell Biol Toxicol; 2008 Apr; 24(2):123-41. PubMed ID: 17610029
[TBL] [Abstract][Full Text] [Related]
16. Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) induces apoptosis and cell cycle arrest in A549 cells through p53 accumulation via c-Jun NH2-terminal kinase-mediated phosphorylation at serine 15 in vitro and in vivo.
Hsu YL; Cho CY; Kuo PL; Huang YT; Lin CC
J Pharmacol Exp Ther; 2006 Aug; 318(2):484-94. PubMed ID: 16632641
[TBL] [Abstract][Full Text] [Related]
17. Potential involvement of serine/threonine protein phosphatases in apoptosis of HepG2 cells during selenite treatment.
Celik HA; Kircelli F; Saydam G; Aydin HH
Biol Trace Elem Res; 2007; 117(1-3):65-75. PubMed ID: 17873393
[TBL] [Abstract][Full Text] [Related]
18. Cancer chemoprevention: selenium as a prooxidant, not an antioxidant.
Drake EN
Med Hypotheses; 2006; 67(2):318-22. PubMed ID: 16574336
[TBL] [Abstract][Full Text] [Related]
19. Exposure of human leukemia NB4 cells to increasing concentrations of selenite switches the signaling from pro-survival to pro-apoptosis.
Guan L; Han B; Li J; Li Z; Huang F; Yang Y; Xu C
Ann Hematol; 2009 Aug; 88(8):733-42. PubMed ID: 19153735
[TBL] [Abstract][Full Text] [Related]
20. Redox modulation of p53: mechanisms and functional significance.
Kim DH; Kundu JK; Surh YJ
Mol Carcinog; 2011 Apr; 50(4):222-34. PubMed ID: 21465572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
